COGT · Cogent Biosciences, Inc. · Proposed Sales
$26.72
-1.03 (-3.70%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$4.65B
Shares
173.99M
Volume · Nov 20
2.13M
Avg daily vol (3M)
2.08M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-27 | ARLENE MORRIS | Director | 45,510 | 2026-08-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-31 | Fairmount Healthcare Fund II L.P. | Director | 7,000,000 | 2026-03-31 | Goldman Sachs & Co. LLC |
| 2026-01-22 | Fairmount Healthcare Fund II L.P. | Director | 3,500,000 | 2026-01-22 | Jefferies LLC |
| 2025-12-29 | JOHN GREEN | Officer | 77,000 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | JOHN ROBINSON | Officer | 90,000 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | EVAN D KEARNS | Officer | 65,000 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | JESSICA SACHS | Officer | 82,642 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–7 of 7 filings
Key facts
CIK
1622229
CUSIP
19240Q201
13F (30d)
323 filings
300 filers
Visit website
Investor relations